

        Patients who meet any of the following criteria will be excluded from participation in the
        study:

          1. Unable to provide verbal informed consent

          2. Uncontrolled bacterial, fungal, or non-COVID viral infection

          3. Active TB or LTBI with < 1 month of treatment

          4. Any prior investigational immunologic therapy (for instance with biologic or JAK
             inhibitor) within 28-days or 3 half-lives of the agent

          5. Any concurrent immunosuppressive medication that the PI believes would put the patient
             at higher risk

          6. Oral or IV corticosteroid for non-COVID-19 indication within the last 7 days at a dose
             of >= 10 mg prednisone or equivalent per day

          7. History of diverticulitis or bowel perforation

          8. ANC <500, Platelets <50,000*

          9. AST/ALT > 5X ULN

         10. Women who are pregnant or planning to get pregnant in the next 90 days;

         11. Any condition that could interfere with, or for Known allergy to the study drug or any
             of its ingredients or known allergy to any other anti IL 6 agents;

         12. Any condition that could interfere with or for which the treatment might interfere
             with, the conduct of the study or interpretation of the study results, or that would,
             in the opinion of the Investigator, increase the risk of the participant by
             participating in the study.
      